UK markets open in 2 hours 2 minutes

Arno Therapeutics, Inc. (ARNI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00030.0000 (0.00%)
At close: 10:25AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 177.66k
Enterprise value -1.94M
Trailing P/E 3.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.14

Trading information

Stock price history

Beta (5Y monthly) 3.36
52-week change 3-85.71%
S&P500 52-week change 326.43%
52-week high 30.0021
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 361
Avg vol (10-day) 3N/A
Shares outstanding 549.35M
Implied shares outstanding 6592.2M
Float 815.03M
% held by insiders 10.00%
% held by institutions 12.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:8
Last split date 330 Oct 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2015
Most-recent quarter (mrq)30 Sept 2016

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-500.04%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -11.06M
Net income avi to common (ttm)-13.7M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.12M
Total cash per share (mrq)0.04
Total debt (mrq)5.09k
Total debt/equity (mrq)N/A
Current ratio (mrq)1.52
Book value per share (mrq)-0.12

Cash flow statement

Operating cash flow (ttm)-7.62M
Levered free cash flow (ttm)-3.95M